ScanTech AI Systems Regains Bid Price Compliance, Resolves Multiple Nasdaq Deficiencies, and Advances Final Phase of Re-Compliance Plan

Core Viewpoint - ScanTech AI Systems Inc. has successfully regained compliance with Nasdaq listing requirements, addressing multiple deficiencies and positioning itself for future stability [2][3][4]. Compliance Progress - The company has received confirmation from Nasdaq that it has met the minimum bid price requirement, maintaining a closing bid price of at least $1.00 per share [2]. - Compliance with Nasdaq Listing Rule 5250(c)(1) has also been regained following the filing of its Form 10-Q for the quarter ended September 30, 2025, and an amended Form 10-Q for the quarter ended June 30, 2025 [3]. - The company has resolved multiple listing deficiencies, including periodic reporting and minimum value of publicly held shares [3]. Remediation Actions - A structured remediation plan has been implemented to address legacy compliance issues, which includes a reverse stock split and engagement with professional advisors [4]. - FSR Group has been engaged to provide strategic and capital markets advisory support, assisting in the coordination of remediation efforts [5]. Remaining Compliance Issues - The company is currently addressing a single remaining deficiency related to the Minimum Value of Listed Securities requirement, with a hearing scheduled for January 22, 2026 [6]. - The company expects its securities to remain listed on Nasdaq pending the outcome of the hearings process [6]. Financial Position and Strategy - Ongoing discussions with creditors are taking place regarding potential restructuring and resolution of outstanding obligations, which are part of the broader remediation plan [7]. - The company aims to strengthen its balance sheet and improve financial flexibility to support long-term stability [7]. Management's Outlook - Management believes that the actions taken demonstrate substantial progress in re-compliance efforts, narrowing remaining issues to a single matter [8].